Literature DB >> 7751581

Sustained effects of ornipressin in hepatorenal syndrome.

E Giostra, P Ruedin, M Cunningham, G Mentha, H Favre, P Jolliet, J C Chevrolet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7751581     DOI： 10.1016/0168-8278(95)80273-8

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  3 in total

1.  Targeting an early and substantial increase in mean arterial pressure is critical in the management of type 1 hepatorenal syndrome: a combined retrospective and pilot study.

Authors:  Geetha Maddukuri; Cindy X Cai; Satish Munigala; Farnaz Mohammadi; Zhiwei Zhang
Journal:  Dig Dis Sci       Date:  2013-10-22       Impact factor: 3.199

2.  A Treat-to-Target Concept to Guide the Medical Management of Hepatorenal Syndrome.

Authors:  Cindy X Cai; Geetha Maddukuri; Navin Jaipaul; Zhiwei Zhang
Journal:  Dig Dis Sci       Date:  2014-12-23       Impact factor: 3.199

3.  Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.

Authors:  Lawrence Mj Best; Suzanne C Freeman; Alex J Sutton; Nicola J Cooper; Eng-Loon Tng; Mario Csenar; Neil Hawkins; Chavdar S Pavlov; Brian R Davidson; Douglas Thorburn; Maxine Cowlin; Elisabeth Jane Milne; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2019-09-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.